The three Rs in the pharmaceutical industry : perspectives of scientists and regulators
Interviews with six drug regulatory reviewers and 11 pharmaceutical research scientists were used to explore their perspectives on obstacles and opportunities for greater implementation of the Three Rs (Replacement, Reduction, Refinement) in drug research and development. Participants generally s...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
2009
|
| Online Access: | http://hdl.handle.net/2429/16739 |